Similar articles

• Etanercept induced multiple sclerosis and transverse myelitis.

  Al Saieg N, Luzar MJ. Al Saieg N, et al. J Rheumatol. 2006 Jun;33(6):1202-4. J Rheumatol. 2006. PMID: 16755671 No abstract available.
• [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].

  Kling A, Dahlqvist R. Kling A, et al. Lakartidningen. 2007 Jan 17-23;104(3):128-30. Lakartidningen. 2007. PMID: 17302117 Review. Swedish. No abstract available.
• [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].

  Hrazdira CL, Mandzjuk B, Skálová M. Hrazdira CL, et al. Cesk Neurol Neurochir. 1974 Sep;37(5):293-300. Cesk Neurol Neurochir. 1974. PMID: 4479029 Czech. No abstract available.
• Recurrent headache due to MS plaque.

  Alstadhaug K, Breivik K, Rusic Z. Alstadhaug K, et al. Headache. 2008 Mar;48(3):453-4. doi: 10.1111/j.1526-4610.2007.01003.x. Epub 2007 Dec 11. Headache. 2008. PMID: 18081822 No abstract available.
• The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery.

  Rijsdijk M, van Wijck AJ, Kalkman CJ, Yaksh TL. Rijsdijk M, et al. Anesth Analg. 2014 May;118(5):1097-112. doi: 10.1213/ANE.0000000000000161. Anesth Analg. 2014. PMID: 24781577 Review.